Immunic (IMUX) Stock Highlights

0.98 | -9.26%

2024-06-27 04:59:32

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohns disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Statistics

Range Today

0.97 1.11

Volume Today 935.3K

Range 1 Year

0.94 3.11

Volume 1 Year 189.4M

Range 3 Year

0.94 14.5

Volume 3 Year 671.62M

Range 10 Year

0.94 1308.8

Volume 10 Year 820.94M

Highlights

Market Capitalization 99.99M (small)

Floating Shares 52.12M

Current Price 0.98

Price To Earnings -0.61

Price To Book 1.2

Earnings Per Share -1.83

Payout Ratio 0%

Performance

Latest -9.26%

1 Month -22.22%

3 Months -23.44%

6 Months -31.94%

1 Year -34.23%

3 Years -92.32%

5 Years -92.5%

10 Years -99.91%

Benchmarks

Market Capitalization

251 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

153 / 368

Free Cashflow

189 / 352

Performance 5 years

283 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.